美银证券发表研究报告指，锦欣生殖(01951.HK) 去年预订收入按年升0.8%至28.12亿元人民币，总利润按年跌6.5%至10.99亿元人民币，毛利率达39.1%，非国际财务报告准则调整后利润按年跌11.7%至4.16亿元人民币。该行指，将集团今年、明年及2027财年收入预测均下调12%，其目标价由3元上调至3.5元，其评级为“买入”。(ca/w)
(港股报价延迟最少十五分钟。沽空资料截至 2025-04-02 12:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.